| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 9 |
| 1 | ASPIRIN | 8 |
| 2 | ASPIRIN 325 MG | 8 |
| 3 | ASPIRIN 81 MG | 8 |
| 4 | PIPERACILLIN SODIUM,TAZOBACTAM SODIUM | 8 |
| 5 | PREDNISOLONE | 8 |
| 6 | PREDNISOLONE ORAL | 8 |
| 7 | PREDNISOLONE ORAL SOLUTION | 8 |
| 8 | FLUOROURACIL | 7 |
| 9 | FLUOROURACIL CREAM, 0.5% | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IBALIZUMAB | 1 | 0.0019 |
| 1 | BIVALIRUDIN | 1 | 0.0010 |
| 2 | ETHIODIZED OIL | 1 | 0.0008 |
| 3 | NERANDOMILAST | 1 | 0.0006 |
| 4 | PIPERACILLIN AND TAZOBACTAM | 7 | 0.0005 |
| 5 | PREDNISOLONE SODIUM PHOSPHATE | 1 | 0.0004 |
| 6 | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | 7 | 0.0004 |
| 7 | DONANEMAB-AZBT | 1 | 0.0003 |
| 8 | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | 1 | 0.0003 |
| 9 | POSACONAZOLE | 5 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD4-directed Blocking Antibody [EPC] | 1 | 0.0019 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 3 | 0.0003 |
| 2 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 3 | Amyloid Beta-directed Antibody [EPC] | 1 | 0.0003 |
| 4 | Interleukin-17A Antagonist [EPC] | 6 | 0.0002 |
| 5 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 8 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |
| 9 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |